老年手术患者与匹配非手术对照者的认知及脑脊液阿尔茨海默病相关生物标志物轨迹
该前瞻性队列研究纳入140例60岁及以上接受大型非神经外科手术患者和51例按年龄、性别、教育年限匹配的非手术对照,比较脑脊液Aβ42、tau、p-tau-181p水平及认知功能变化。结果显示手术组与非手术对照组在术后24小时、6周及1年的脑脊液阿尔茨海默病相关生物标志物变化上无显著差异,且未发现手术加速认知下降的证据。
要点
- 老年非心脏非神经外科手术未加速脑脊液Aβ、tau、p-tau等阿尔茨海默病相关生物标志物变化。
- 匹配的非手术对照组1年后认知下降反而大于手术组,但校正失访后差异消失。
- 研究不支持麻醉和手术加速老年患者阿尔茨海默病病理或认知衰退的假设。
核心结论
- 在1年随访期内,与匹配的非手术对照相比,无证据表明老年患者接受麻醉和非心脏非神经外科手术会加速脑脊液阿尔茨海默病相关生物标志物变化或导致更严重的认知下降。
研究设计与样本
- 前瞻性队列研究,纳入140例60岁及以上接受大型非神经外科手术患者和51例非手术对照,按年龄、性别、教育年限进行分层匹配。
- 在手术前后及对照组相同时点测量脑脊液Aβ42、tau、p-tau-181p水平和认知功能。
主要发现
- 手术组与对照组在基线至术后24小时或6周的脑脊液Aβ、tau、p-tau水平及tau/Aβ、p-tau/Aβ比值变化上无显著组间差异或交互效应(Bonferroni P > 0.05)。
- 术后1年两组脑脊液标志物水平无差异(P > 0.05)。
- 非手术对照组基线认知与手术组无差异(均数差0.19,95%CI -0.06至0.43;P=0.132),但1年后认知下降大于手术组(β=-0.31,95%CI -0.45至-0.17;P<0.001)。
- 采用插补或逆概率加权处理失访后,两组1年认知变化无差异。
临床怎么用
- 对于60岁及以上接受大型非心脏非神经外科手术的老年患者,现有证据未显示麻醉和手术会加速阿尔茨海默病相关脑脊液生物标志物变化或认知下降。
- 围术期认知功能评估和脑脊液生物标志物监测不应仅基于手术暴露而常规进行,需结合个体风险综合判断。
局限性
- 研究仅纳入非心脏非神经外科手术患者,结论不能外推至心脏或神经外科手术。
- 认知数据存在失访,虽采用插补和逆概率加权分析,仍可能影响结果解释。
- 随访时间为1年,无法评估更长期的认知或生物标志物轨迹。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anesthesia and/or surgery accelerate Alzheimer's disease pathology and cause memory deficits in animal models, yet there is a lack of prospective data comparing cerebrospinal fluid (CSF) Alzheimer's disease-related biomarker and cognitive trajectories in older adults who underwent surgery versus those who have not. Thus, the objective here was to better understand whether anesthesia and/or surgery contribute to cognitive decline or an acceleration of Alzheimer's disease-related pathology in older adults. METHODS: The authors enrolled 140 patients 60 yr or older undergoing major nonneurologic surgery and 51 nonsurgical controls via strata-based matching on age, sex, and years of education. CSF amyloid β (Aβ) 42, tau, and p-tau-181p levels and cognitive function were measured before and after surgery, and at the same time intervals in controls. RESULTS: The groups were well matched on 25 of 31 baseline characteristics. There was no effect of group or interaction of group by time for baseline to 24-hr or 6-week postoperative changes in CSF Aβ, tau, or p-tau levels, or tau/Aβ or p-tau/Aβ ratios (Bonferroni P > 0.05 for all) and no difference between groups in these CSF markers at 1 yr (P > 0.05 for all). Nonsurgical controls did not differ from surgical patients in baseline cognition (mean difference, 0.19 [95% CI, -0.06 to 0.43]; P = 0.132), yet had greater cognitive decline than the surgical patients 1 yr later (β, -0.31 [95% CI, -0.45 to -0.17]; P < 0.001) even when controlling for baseline differences between groups. However, there was no difference between nonsurgical and surgical groups in 1-yr postoperative cognitive change in models that used imputation or inverse probability weighting for cognitive data to account for loss to follow up. CONCLUSIONS: During a 1-yr time period, as compared to matched nonsurgical controls, the study found no evidence that older patients who underwent anesthesia and noncardiac, nonneurologic surgery had accelerated CSF Alzheimer's disease-related biomarker (tau, p-tau, and Aβ) changes or greater cognitive decline.
引用
- Reese M, Wong MK, Cheong V, et al. Cognitive and Cerebrospinal Fluid Alzheimer's Disease-related Biomarker Trajectories in Older Surgical Patients and Matched Nonsurgical Controls. Anesthesiology. 2024. PMID: 38324729. doi:10.1097/ALN.0000000000004924
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。